Neuropsychopharmacology,
Год журнала:
2024,
Номер
49(12), С. 1916 - 1924
Опубликована: Июль 1, 2024
Prevailing
hypotheses
on
the
mechanisms
of
antidepressant
action
posit
that
antidepressants
directly
counteract
deficiencies
in
major
neurotransmitter
signaling
systems
underlie
depression.
The
rapidly
acting
ketamine
has
been
postulated
to
correct
excess
glutamatergic
via
antagonism
leading
rescue
neuronal
structural
deficits
and
reversal
behavioral
symptoms.
We
studied
this
premise
using
systemic
administration
acetylcholinesterase
inhibitor
physostigmine,
which
shown
elicit
a
shorter-term
period
depressed
mood
humans
cholinergic
mechanisms.
observed
physostigmine
induces
acute
stress
tandem
with
long
term
depression
glutamate
release
hippocampus
mice.
However,
acts
re-establish
synaptic
efficacy
postsynaptic
behaviorally
masks
reduction
passive
coping
induced
by
physostigmine.
These
results
underscore
divergence
underlying
changes
highlight
how
distinct
may
neuropsychiatric
disorders
versus
their
treatment.
Translational Psychiatry,
Год журнала:
2025,
Номер
15(1)
Опубликована: Апрель 19, 2025
Depression
has
been
linked
to
cortico-limbic
brain
regions,
and
ketamine
is
known
for
its
rapid
antidepressant
effects.
However,
how
these
regions
encode
depression
collaboratively
regulates
exert
prompt
effects
through
mesoscale
brain-wide
fluctuations
remain
elusive.
In
this
study,
we
used
a
multidisciplinary
approach,
including
multi-region
in
vivo
recordings
mice,
chronic
social
defeat
stress
(CSDS),
machine
learning,
construct
Mesoscale
Brain-Wide
Fluctuation
Analysis
platform
(MBFA-platform).
This
analyzes
the
of
multiple
from
perspective
local
field
potential
oscillations
network
dynamics.
The
decoder
results
demonstrate
that
our
MBFA
can
accurately
classify
Control/CSDS
ketamine/saline-treated
groups
based
on
neural
oscillation
activities
among
eight
regions.
We
found
multiple-region
LFPs
patterns
are
disrupted
CSDS-induced
avoidance,
with
basolateral
amygdala
playing
key
role.
Ketamine
primarily
exerts
compensatory
dynamics,
contributing
effect.
These
findings
highlight
as
an
interdisciplinary
tool
revealing
underlying
complex
emotional
pathologies,
providing
insights
into
etiology
psychiatry.
Furthermore,
platform's
evaluation
capabilities
present
novel
approach
psychiatric
therapeutic
interventions.
Psychopharmacology,
Год журнала:
2025,
Номер
unknown
Опубликована: Май 8, 2025
Abstract
Rationale
(S)
-Ketamine,
which
is
used
to
treat
depression,
has
significant
undesirable
effects
and
potential
for
abuse.
A
safe
alternative
-ketamine
(R)
-ketamine.
The
relationship
between
the
mGlu
5
receptor
unknown,
although
screening
tests
indicate
possibility
of
potentiation
antidepressant
effect
by
negative
allosteric
modulator
(NAM).
Objectives
We
aimed
investigate
whether
antidepressant-like
receptor-dependent.
Specifically,
we
investigated
enhancing
using
partial
NAM,
2-(2-(3-methoxyphenyl)ethynyl)-5-methylpyridine
(M-5MPEP),
in
a
chronic
unpredictable
mild
stress
(CUMS)
model
depression
mice.
Methods
on
availability
mouse
brain
was
an
autoradiographic
method.
Animal
behaviors
reflecting
anhedonia,
apathy,
helplessness
were
analyzed
study
rapid
sustained
combined
administration
M-5MPEP.
Hippocampal
protein
levels
measured
via
Western
blotting.
Results
-Ketamine
altered
several
regions.
Importantly,
hippocampus,
reversed
CUMS-induced
effects.
Behavioral
studies
revealed
that
M-5MPEP
enhanced
effectiveness
subeffective
dose
This
drug
combination
effectively
reduced
apathy-
anhedonia-like
behavior
symptoms.
Changes
hippocampal
eukaryotic
elongation
factor2
(eEF2)
tropomyosin
kinase
B
(TrkB)
accompanied
these
Conclusions
weakening
function
hippocampus
appears
be
related
effect,
coadministration
M-5MPEP,
might
increase
its
activity.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(13), С. 10814 - 10814
Опубликована: Июнь 28, 2023
Stress
is
a
primary
risk
factor
in
the
onset
of
neuropsychiatric
disorders,
including
major
depressive
disorder
(MDD).
We
have
previously
used
chronic
mild
stress
(CMS)
model
depression
male
rats
to
show
that
CMS
induces
morphological,
functional,
and
molecular
changes
hippocampus
vulnerable
animals,
majority
which
were
recovered
using
acute
subanesthetic
ketamine
just
24
h.
Here,
we
focused
our
attention
on
medial
prefrontal
cortex
(mPFC),
brain
area
regulating
emotional
cognitive
functions,
asked
whether
vulnerability/resilience
antidepressant
effects
associated
with
functional
mPFC
rats.
found
most
alterations
induced
by
selectively
observed
stress-vulnerable
animals
rescued
ketamine,
while
others
only
resilient
or
treatment.
Importantly,
few
these
modifications
also
demonstrated
hippocampus,
are
specific
mPFC.
Overall,
results
suggest
rescues
brain-area-specific
glutamatergic
stress.
Abstract
Locus
coeruleus
(LC)
dysfunction
is
involved
in
the
pathophysiology
of
depression;
however,
neural
circuits
and
specific
molecular
mechanisms
responsible
for
this
remain
unclear.
Here,
it
shown
that
activation
tyrosine
hydroxylase
(TH)
neurons
LC
alleviates
depression‐like
behaviors
susceptible
mice.
The
dorsolateral
septum
(dLS)
most
physiologically
relevant
output
from
under
stress.
Stimulation
TH
‐dLS
SST
innervation
with
optogenetic
chemogenetic
tools
bidirectionally
can
regulate
both
male
female
Mechanistically,
found
brain‐derived
neurotrophic
factor
(BDNF),
but
not
norepinephrine,
required
circuit
to
produce
antidepressant‐like
effects.
Genetic
overexpression
BDNF
or
supplementation
protein
dLS
sufficient
Furthermore,
viral
knockdown
abolishes
effect
ketamine,
fluoxetine.
Collectively,
these
findings
underscore
notable
role
pathway
depression
via
BDNF‐TrkB
signaling.
Neuropsychopharmacology,
Год журнала:
2024,
Номер
49(12), С. 1916 - 1924
Опубликована: Июль 1, 2024
Prevailing
hypotheses
on
the
mechanisms
of
antidepressant
action
posit
that
antidepressants
directly
counteract
deficiencies
in
major
neurotransmitter
signaling
systems
underlie
depression.
The
rapidly
acting
ketamine
has
been
postulated
to
correct
excess
glutamatergic
via
antagonism
leading
rescue
neuronal
structural
deficits
and
reversal
behavioral
symptoms.
We
studied
this
premise
using
systemic
administration
acetylcholinesterase
inhibitor
physostigmine,
which
shown
elicit
a
shorter-term
period
depressed
mood
humans
cholinergic
mechanisms.
observed
physostigmine
induces
acute
stress
tandem
with
long
term
depression
glutamate
release
hippocampus
mice.
However,
acts
re-establish
synaptic
efficacy
postsynaptic
behaviorally
masks
reduction
passive
coping
induced
by
physostigmine.
These
results
underscore
divergence
underlying
changes
highlight
how
distinct
may
neuropsychiatric
disorders
versus
their
treatment.